Morgan Stanley Call 105 NOVN 19.1.../ DE000MG1WJK9 /
21/06/2024 21:22:36 | Diferencia-0.010 | Bid22:00:35 | Ask22:00:35 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.390EUR | -2.50% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
NOVARTIS N | 105.00 CHF | 19/12/2025 | Call |
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
6:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
3:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
3:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página